TYK Medicines (HKG:2410) said the Listing Committee of the Stock Exchange of Hong Kong approved the listing of the company's 173,641,645 H shares on the exchange on Monday, a same-day bourse filing said.
The said H shares are to be converted from the same number of unlisted shares held by 25 company shareholders. The exchange also granted permission to deal in the converted H shares to the company.
The company had applied to the Exchange for the conversion and listing of the said shares on Sept. 13, 2024.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。